Zenosense, Inc. (ZENO) – Cardiac Triage Technology Proves Capability
Joint Venture MIDS technology doubles detection capability in second testing round MIDS Technology aims to provide ambulance personnel, ERs with a fast, easy, low-cost and powerful device to diagnose potential cardiac symptoms Chest pain diagnosis is one of the most common challenges for outpatient medical providers to assess When first responders provide treatment to patients complaining of chest pain, they face the critical task of determining what medical intervention is necessary with as much immediacy as possible. Although such diagnoses can be difficult, particularly away from a clinical laboratory setting, Zenosense Inc. (OTC: ZENO), through a joint-venture ownership in MIDS…
